Showing results (1271-1280 of 2,005) with videos related to

Sort By:
Pageof 201
Nature Communications|January 26, 2024
Thermo-optic epsilon-near-zero effectsJiaye Wu, Marco Clementi, Chenxingyu Huang, et al.
Light, Science & Applications|December 7, 2023
A chip-scale second-harmonic source via self-injection-locked all-optical polingMarco Clementi, Edgars Nitiss, Junqiu Liu, et al.
Journal of Diabetes Research|January 19, 2016
Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal EnvironmentJayashree Dolpady, Chiara Sorini, Caterina Di Pietro, et al.
Journal of Obesity|June 7, 2017
Short- and Long-Term, 11-22 Years, Results after Laparoscopic Nissen Fundoplication in Obese versus Nonobese PatientsMario Schietroma, Federica Piccione, Marco Clementi, et al.
Annals of Neurology|March 20, 1998
Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patientsG Martino, F Grohovaz, E Brambilla, et al.
Science Advances|September 14, 2020
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivityElias H Augestad, Matteo Castelli, Nicola Clementi, et al.
BMC Research Notes|March 25, 2020
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot studyStefano Guadagni, Giammaria Fiorentini, Ioannis Papasotiriou, et al.
Il Giornale Di Chirurgia|August 8, 2002
[Pneumatosis cystoides intestinalis in emergencies: clinical management and treatment. 2 case reports]M Assenza, G De Angelis, C M Moschella, et al.
Cells|March 22, 2020
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse ModelGabriele Di Sante, Susanna Amadio, Beatrice Sampaolese, et al.
Expert Opinion on Drug Safety|September 15, 2019
Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®Carla Carnovale, Faizan Mazhar, Elena Arzenton, et al.
Pageof 201